Health inspection·January 16, 2026

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and facility P&P review, the facility failed to provide the necessary pharmaceutical services for one of six sampled residents (Resident 2). * Resident 2 did not receive the medication as ordered by the physician. This failure posed the risk of Resident 2 receiving unnecessary medication and negative health consequences.Findings: Review of facility's P&P titled Medication Administration revised 12/19/22, showed the medications are administered by licensed nurses, or other staff who are legally authorized to do so in this state, as ordered by the physician and in accordance with professional standards of practice, with compliance guidelines to include: obtain and record vital signs, when applicable or per physician orders. When applicable, hold medication for those vital signs outside the physician's prescribed parameters. Medical record review for Resident 2 was initiated on 1/16/26. Resident 2 was admitted to the facility on [DATE]. Review of Resident 2's H&P examination dated 8/22/25, showed Resident 2 with history of Congestive Heart Failure and hypotension. Resident 2 had no capacity to make medical decisions. Review of Resident 2's Order Summary Report showed an order dated 8/20/25, for Midodrine HCl (medication to treat low blood pressure)10 mg tablet. Give one tablet via GT every eight hours for hypotension, hold if SBP greater than 100 mmHg. Review of Resident 2's care plan for hypotension dated 9/4/25, showed to administer Midodrine HCl tablet for hypotension, monitor the vital signs and notify the MD of significant abnormalities. Further review of Resident 2's MAR for January 2026 showed Resident 2 was administered Midodrine 10 mg tablet on the following dates and times:- 1/2/26, BP 106/61 mmHg, medication was administered at 0600 hours- 1/5/26, BP: 156/78 mmHg, medication was administered at 2200 hours- 1/7/26, BP: 102/60 mmHg, medication was administered at 1400 hours- 1/9/26, BP: 112/71 mmHg, medication was administered at 0600 hours and BP: 139/70 mmHg, medication was administered at 2200 hours- 1/10/26, BP: 139/68 mmHg, medication was administered at 2200 hours- 1/11/26, BP: 124/76 mmHg, medication was administered at 0600 hours and BP: 136/70 mmHg, medication was administered at 2200 hours- 1/13/26, BP: 127/64 mmHg, medication was administered at 2200 hours1/14/26, BP: 116/68 mmHg, medication was administered at 2200 hours- 1/15/26, BP: 106/66 mmHg, medication was administered at 1400 hours and BP: 138/68 mmHg, medication was administered at 2200 hours- 1/16/26, BP: 126/72 mmHg, medication was administered at 0600 hours and BP: 108/66 mmHg, medication was administered at 1400 hours On 1/16/26 at 1525 hours, an interview and concurrent medical record review for Resident 2 was conducted with RN 1. RN 1 stated Resident 2 had an order for Midodrine 10 mg every eight hours for hypotension and to hold if the SBP was greater than 100 mmHg. RN 1 verified the above findings and stated the medication should not have been administered on the above dates and times. RN 1 further stated it could affect the resident's health. On 1/16/26 at 1645 hours, the Administrator and Nursing Consultant were informed and acknowledged the findings. Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 555103 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555103 B. Wing A. Building (X3) DATE SURVEY COMPLETED 01/16/2026 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE French Park Care Center 600 E Washington Avenue Santa Ana, CA 92701 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)